Bioventus Inc reports results for the quarter ended in March - Earnings Summary

Bioventus

07/05/2024 18:08

* Bioventus Inc  BVS.OQ  reported quarterly adjusted
earnings of 7
cents​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of -26
cents.  The mean expectation of three analysts for the quarter
was for a loss of 7 cents per share. Wall Street expected
results to range from -11 cents to -4 cents per share.
    * Revenue rose 8.7% to $129.46 million from a year ago;
analysts
expected $118.38 million. 
    * Bioventus Inc's reported EPS for the quarter was a loss
of 7
cents​.
    * The company reported a quarterly loss of $4.57 million.
    * Bioventus Inc shares had fallen by 23.1% this quarter and
lost 24.1% so far this year.

FORECAST CHANGES
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "hold"

Wall Street's median 12-month price target for Bioventus Inc is
$8.00 
This summary was machine generated from LSEG data May 7 at 05:08
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.07          0.07           Beat
 Dec. 31 2023      0.02           0.07           Beat
 Sep. 30 2023      -0.02          0.05           Beat
 Jun. 30 2023      0.00           0.14           Beat